Literature DB >> 11449925

Enhancing adherence to HAART: a pilot program of modified directly observed therapy.

M S Stenzel1, M McKenzie, J A Mitty, T P Flanigan.   

Abstract

Based on the model of directly observed therapy (DOT) for tuberculosis, we implemented an uncontrolled pilot program of modified DOT to increase adherence to HAART. Participants met every weekday with an outreach worker who observed them taking the morning dose of HAART. Thirty-seven patients with a history of poor adherence were enrolled and followed for a mean duration of 10 months. The program was feasible and well accepted by the participants. Self-reported adherence to nonobserved doses improved, and those who remained in the program for a year (n = 18) demonstrated a mean 1.53-log decrease from baseline in plasma HIV RNA level.

Entities:  

Mesh:

Year:  2001        PMID: 11449925

Source DB:  PubMed          Journal:  AIDS Read        ISSN: 1053-0894


  9 in total

1.  Directly observed therapy with azithromycin for skin and soft tissue infections in injection drug users.

Authors:  Harout K Tossonian; Brian Conway; Jesse D Raffa; Mark Viljoen; Milan Khara; Annabel Mead; Heather Culbert; Stanley Devlaming
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

2.  Attitudes to directly observed antiretroviral treatment in a workplace HIV care programme in South Africa.

Authors:  Liesl S Page-Shipp; Salome Charalambous; Surita Roux; Belinda Dias; Clement Sefuti; Gavin J Churchyard; Alison D Grant
Journal:  Sex Transm Infect       Date:  2007-06-13       Impact factor: 3.519

Review 3.  Adherence to antiretroviral therapy: an update of current concepts.

Authors:  Gregory M Lucas; Albert W Wu; Laura W Cheever
Journal:  Curr HIV/AIDS Rep       Date:  2004-12       Impact factor: 5.071

Review 4.  Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.

Authors:  Jessica E Hart; Christie Y Jeon; Louise C Ivers; Heidi L Behforouz; Adolfo Caldas; Peter C Drobac; Sonya S Shin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

Review 5.  Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.

Authors:  S Rueda; L Y Park-Wyllie; A M Bayoumi; A M Tynan; T A Antoniou; S B Rourke; R H Glazier
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 6.  Once-daily therapies for the treatment of HIV infection.

Authors:  Karen T Tashima; Jennifer Adelson Mitty
Journal:  Curr HIV/AIDS Rep       Date:  2006-07       Impact factor: 5.071

Review 7.  Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.

Authors:  Geetanjali Chander; Seth Himelhoch; Richard D Moore
Journal:  Drugs       Date:  2006       Impact factor: 9.546

8.  A qualitative examination of the indirect effects of modified directly observed therapy on health behaviors other than adherence.

Authors:  Andrea Bradley-Ewing; Domonique Thomson; Megan Pinkston; Kathy J Goggin
Journal:  AIDS Patient Care STDS       Date:  2008-08       Impact factor: 5.078

9.  Using community health workers to improve clinical outcomes among people living with HIV: a randomized controlled trial.

Authors:  Sonjia Kenya; Jamal Jones; Kristopher Arheart; Erin Kobetz; Natasha Chida; Shelly Baer; Alexis Powell; Stephen Symes; Tai Hunte; Anne Monroe; Olveen Carrasquillo
Journal:  AIDS Behav       Date:  2013-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.